Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2012
02/15/2012EP2418220A2 Interferon alpha antibodies and their uses
02/15/2012EP2418212A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
02/15/2012EP2417984A1 Method for treatment of blood tumor using anti-tim-3 antibody
02/15/2012EP2417974A1 Combination therapy for treatment of immune disorders
02/15/2012EP2417164A1 Bispecific anti-erbb-2/anti-c-met antibodies
02/15/2012EP2417163A2 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
02/15/2012EP2417162A2 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
02/15/2012EP2417161A1 Antibodies against il-17br
02/15/2012EP2417160A1 Bispecific anti-erbb-1/anti-c-met antibodies
02/15/2012EP2417159A1 Bispecific anti-erbb-3/anti-c-met antibodies
02/15/2012EP2417158A1 Dkk-1 antibodies
02/15/2012EP2417157A1 Human monoclonal antibody specific for lipolysaccarides (lps) of serotype lats 01 of pseudomonas aeruginosa
02/15/2012EP2417156A1 Trivalent, bispecific antibodies
02/15/2012EP2416807A1 Novel strategies for improved cancer vaccines
02/15/2012EP2416805A1 Amatoxin-armed target-binding moieties for the treatment of cancer
02/15/2012EP2416804A2 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
02/15/2012EP2416803A1 New methods for treatment of inflammatory diseases
02/15/2012EP1966243B1 Tgf-beta binding antibodies
02/15/2012EP1951891B1 Cancer antigen mage-a9 and uses thereof
02/15/2012EP1765861B1 Fgfr binding peptides
02/15/2012EP1648506B1 Method for treating synovial sarcoma
02/15/2012EP1636268B1 Humanized antibodies that recognize beta amyloid peptide
02/15/2012EP1532446B1 G-protein coupled receptor ligands and methods
02/15/2012EP1328293B1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
02/15/2012EP1309705B1 Multivalent target binding protein
02/15/2012CN1929862B 拮抗性抗-cd40单克隆抗体治疗慢性淋巴细胞性白血病的应用 Monoclonal antibody antagonist anti -cd40 application to treat chronic lymphocytic leukemia
02/15/2012CN1609617B 诊断与预防严重急性呼吸道综合症（sars）的组合物和方法 Diagnosis and compositions and methods for the prevention of severe acute respiratory syndrome (sars) of
02/15/2012CN102356092A Bispecific anti-her antibodies
02/15/2012CN102356091A Immuno-based botulinum toxin serotype a activity assays
02/15/2012CN102356090A Combination gas vaccines and therapeutics
02/15/2012CN102352362A Optimized danio rerio vitellogenin gene, and expression carrier and application thereof
02/15/2012CN102351947A Ev71 early diagnosis method and reagent kit
02/15/2012CN101497664B 人羧肽酶A抑制因子Latexin的单克隆抗体及其应用 People carboxypeptidase A inhibitor Latexin monoclonal antibody and its application
02/14/2012US8114977 Proteins derived from white spot syndrome virus and uses thereof
02/14/2012US8114969 Immunotoxin derived from a recombinant human autoantibody and method of using thereof
02/14/2012US8114968 Metalloproteinase-12 specific monoclonal antibody
02/14/2012US8114967 Constructs and libraries comprising antibody surrogate light chain sequences
02/14/2012US8114966 Peptide-based passive immunization therapy for treatment of atherosclerosis
02/14/2012US8114965 Compositions of PSMA antibodies
02/14/2012US8114964 Anti-MCP-1 antibodies, compositions, methods and uses
02/14/2012US8114849 Retinal dystrophy-associated protein and uses thereof
02/14/2012US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
02/14/2012US8114667 Hybridoma producing antibodies to Lawsonia intracellularis
02/14/2012US8114666 Hybridoma producing antibodies to lawsonia intracellularis
02/14/2012US8114617 Method for quantifying phosphokinase activity on proteins
02/14/2012US8114606 Aldo-keto reductase specific immunoglobulin for use in diagnosis, classification and imaging of cell proliferative disorders
02/14/2012US8114593 Cancer biomarker genes and gene products and methods for using the same
02/14/2012US8114586 Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes
02/14/2012US8114431 Biomolecular coating for implants
02/14/2012US8114417 Recombinant protective protein from Streptococcus pneumoniae
02/14/2012US8114408 Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof
02/14/2012US8114404 Method and composition for altering a B cell mediated pathology
02/14/2012US8114403 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
02/14/2012US8114402 Compositions and methods for the therapy and diagnosis of influenza
02/14/2012US8114401 Chlamydia trachomatis antigens
02/14/2012US8114399 Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
02/14/2012CA2597545C Antibody for assay of adamts13 activity and method for assaying the activity
02/14/2012CA2387870C Stabilized proteins
02/09/2012WO2012019024A2 Her3-binding molecules and immunoconjugates thereof
02/09/2012WO2012018801A2 Suppressing bone loss with anti-il-19 antibody
02/09/2012WO2012018790A2 Dual variable domain immunoglobulins and uses thereof
02/09/2012WO2012018771A1 Chronic lymphocytic leukemia (cll) biomarkers
02/09/2012WO2012018764A1 Mice that make binding proteins comprising vl domains
02/09/2012WO2012018687A1 Covalent diabodies and uses thereof
02/09/2012WO2012018476A1 Antibodies relating to pivka-ii and uses thereof
02/09/2012WO2012018260A1 Epidermal growth factor receptor targeted immune therapy
02/09/2012WO2012017472A1 Process for the production of anti-idiotype monoclonal antibodies for diagnostic and/or therapeutic use
02/09/2012WO2012017328A2 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
02/09/2012WO2012017208A1 Methods and compounds for the diagnosis and treatment of
02/09/2012WO2012017156A1 Concentrated human immunoglobulin composition
02/09/2012WO2012017085A1 Antibodies against 6-sulfo-lacnac-positive human dendritic cells, and their use
02/09/2012WO2012017003A1 Anti-mhc antibody anti-viral cytokine fusion protein
02/09/2012WO2012016429A1 Compositions and methods for treating hepatitis virus infection
02/09/2012US20120036599 Novel fungal enzymes
02/09/2012US20120036590 Interferon-like protein zcyto21
02/09/2012US20120036589 Vaccine
02/09/2012US20120035346 Luminescent compounds
02/09/2012US20120035344 Nucleophilic catalysts for oxime linkage
02/09/2012US20120035073 Compositions and methods for the treatment of immune related diseases
02/09/2012US20120034690 Cell lines producing blocking antibodies to human RANKL
02/09/2012US20120034689 Mycobacterial antigens expressed during latency
02/09/2012US20120034656 Neutralising Antibody Molecules Having Specificity for Human IL-17
02/09/2012US20120034651 Akt activity specifically inhibiting polypeptide
02/09/2012US20120034631 Anti-lysophospholipid antibody design using antibody structures
02/09/2012US20120034626 Neoplasia-Specific Autoantibodies and Methods
02/09/2012US20120034611 Method for detecting presumed iga nephropathy and method for screening iga nephropathy patients
02/09/2012US20120034609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
02/09/2012US20120034604 Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker
02/09/2012US20120034317 Prediction of Response to Platinum-Based Therapy
02/09/2012US20120034247 Monomethylvaline compounds capable of conjugation to ligands
02/09/2012US20120034246 Monomethylvaline compounds capable of conjugation to ligands
02/09/2012US20120034245 Single-chain multivalent binding proteins with effector function
02/09/2012US20120034243 Method of Administering an Antibody
02/09/2012US20120034242 Cytokine-expressing cellular vaccine combinations
02/09/2012US20120034241 Immunogenic compositions and uses thereof
02/09/2012US20120034239 Proteins with improved solubility and methods for producing and using same
02/09/2012US20120034237 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
02/09/2012US20120034234 Methods for the treatment or prevention of systemic sclerosis
02/09/2012US20120034232 Tlr3 binding agents
02/09/2012US20120034231 Compositions and methods of use for therapeutic antibodies
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 1494